Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 5/20 | 0.59 |
| ▸ | ATM | Q13315 | 2/20 | 0.59 |
| ▸ | CFTR | P13569 | 1/20 | 0.59 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.59 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.59 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.41 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 6/20 | 0.40 |
| ▸ | CA2 | P00918 | 6/20 | 0.40 |
| ▸ | CA9 | Q16790 | 6/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12285238 | 0.90 | ABCB1 (0.76) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL10013900 | 0.90 | ABCB1 (0.59) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL10145544 | 0.88 | USP2 (0.55) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL16985958 | 0.87 | ABCB1 (0.56) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL13966918 | 0.86 | ABCB1 (0.61) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL12697372 | 0.85 | ABCB1 (0.45) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL609855 | 0.85 | ABCB1 (0.45) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL6056016 | 0.85 | ABCB1 (0.45) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL14071809 | 0.85 | USP2 (0.59) | ABCB1USP2ATMCFTRPAX8 | |
| SCHEMBL16232679 | 0.84 | ABCB1 (0.58) | ABCB1USP2ATMCFTRPAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246144-A1 | A SET OF MITOCHONDRIA-TARGETED COMPOUNDS | MITOTECH S.A. (LU) | 2021-08-12 | — | — | US | disclosed |
| US-9012166-B2 | Method for assaying histone methylation enzyme activity | KYUSHU INSTITUTE OF TECHNOLOGY (JP) | 2015-04-21 | — | — | US | disclosed |
| US-20130029878-A1 | Method for Assaying Histone Methylation Enzyme Activity | KYUSHU INSTITUTE OF TECHNOLOGY (JP) | 2013-01-31 | — | — | US | disclosed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-7301025-B2 | N-(2-(2-(alkyl[carbamoyl, carbonyloxy or ureido]alkyl)pyridinium)-5-(carboxy or sulfo)phenyl-8-((2-(N-alkyl[carbamoyl or ureido]alkyl)pyridinyl) xanthene ligands complexed with a metal or metal-containing moiety; magenta dye with improved heat resistance; hot melts or phase change inks | XEROX CORPORATION (US) | 2007-11-27 | — | — | US | disclosed |
| US-7176317-B2 | Colorant compounds | XEROX CORPORATION (US) | 2007-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130029878-A1 | Method for Assaying Histone Methylation Enzyme Activity | EHMT1, DOT1L, EHMT2 | ABCB1 4372/4885USP2 545/4885ATM 2732/4885 |
| US-20210246144-A1 | A SET OF MITOCHONDRIA-TARGETED COMPOUNDS | COQ8A, TIMM50, TIMM10 | ABCB1 165/4885USP2 4585/4885ATM 2564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.